Enteral feeds: Less than 1.5 kcal/mL and 5 g (or more) protein/100 mL(product list continued)
Not suitable for use in child under 1 year unless otherwise stated; not recommended for child 1–6 years
Product Formulation Energy Protein Carbohydrate Fat Fibre Special Characteristics ACBS Indications Presentation & Flavour
Nutrison®MCT
(Nutricia Ltd)
Liquid (tube feed)
per 100 mL420 kJ
( 100 kcal)5 g
cows’milk12. 6 g
(sugars 1 g)3. 3 g
(MCT 61 %)Nil Gluten-free
Residual lactoseBorderline substances standard
ACBS indications p. 1012Nutrison MCT liquid: 1000 ml =
£ 10. 56Nutrison®Protein
Plus
(Nutricia Ltd)
Liquid (tube feed)
per 100 mL525 kJ
( 125 kcal)6. 3 g
cows’milk14. 2 g
(sugars 1. 1 g)4. 9 g Nil Gluten-free
Residual lactoseBorderline substances standard
ACBS indications p. 1012Nutrison Protein Plus liquid: 1 litre =
£ 10. 84Nutrison®Protein
Plus Multi Fibre
(Nutricia Ltd)
Liquid (tube feed)
per 100 mL535 kJ
( 128 kcal)6. 3 g
cow’s milk14. 1 g
(sugars 1. 0 g)4. 9 g 1. 5 g Gluten-free
Residual lactoseDisease related malnutrition Nutrison Protein Plus Multifibre
liquid: 1 litre = £ 12. 08Osmolite®Plus
(Abbott Laboratories
Ltd)
Liquid (tube feed)
per 100 mL508 kJ
( 121 kcal)5. 55 g
caseinates15. 8 g
(sugars 730 mg)3. 93 g Nil Gluten-free
Residual lactoseBorderline substances standard
ACBS indications p. 1012
Not suitable for child under 10 yearsOsmolite Plus liquid: 1000 ml =
£ 10. 29 ; 500 ml = £ 5. 66 ; 1500 ml =
£ 15. 39Peptamen®HN
(Nestle Health
Science)
Liquid (tube feed)
per 100 mL556 kJ
( 133 kcal)6. 6 g
whey protein
hydrolysates15. 6 g
(sugars 1. 4 g)4. 9 g
(MCT 70 %)Nil Gluten-free
Residual lactose
Hydrolysed with pork trypsinShort bowel syndrome, intractable
malabsorption, proven inflammatory
bowel disease, bowel fistula
Not suitable for child under 3 yearsPeptamen HN liquid: 500 ml = £ 7. 60Perative®
(Abbott Laboratories
Ltd)
Liquid (sip or tube
feed)
per 100 mL552 kJ
( 131 kcal)6. 7 g
caseinate
whey protein
hydrolysates17. 7 g
(sugars 660 mg)3. 7 g
(MCT 42 %)Nil Gluten-free
Residual lactoseBorderline substances standard
ACBS indications p. 1012
Not suitable for child under 5 yearsPerative liquid: 1000 ml = £ 14. 77 ;
500 ml = £ 8. 00Enteral feeds: More than 1.5 kcal/mL and 5 g (or more) protein/100 mL
Not suitable for use in child under 1 year unless otherwise stated; not recommended for child 1–6 years
Product Formulation Energy Protein Carbohydrate Fat Fibre Special Characteristics ACBS Indications Presentation & Flavour
Ensure®Twocal
(Abbott Laboratories
Ltd)
Liquid (sip or tube
feed)
per 100 mL838 kJ
( 200 kcal)8. 4 g
cows’milk21 g
(sugars 4. 5 g)8. 9 g 1 g Gluten-free
Residual lactoseBorderline substances standard
ACBS indications p. 1012 ; also
haemodialysis and CAPDEnsure TwoCal liquid: banana,
neutral, strawberry, vanilla 200 ml
=£ 2. 22Enteral feeds (non-disease specific): Child under 12 years
Enteral feeds, Child: Less than 1 kcal/mL and less than 4 g protein/100 mL
Product Formulation Energy Protein Carbohydrate Fat Fibre Special Characteristics ACBS Indications Presentation & Flavour
Nutrini®Low Energy
Multi Fibre
(Nutricia Ltd)
Liquid (tube feed)
per 100 mL315 kJ
( 75 kcal)2. 1 g
whey protein
and caseinate9. 3 g
(sugars 600 mg)3. 3 g 800 mg Gluten-free
Residual lactose
Contains fish oilBorderline substances paediatric ACBS
indications p. 1012 except bowel
fistula, in child 1 – 6 years, body-weight
8 – 20 kgNutrini Low Energy Multifibre liquid:
200 ml = £ 2. 79 ; 500 ml = £ 7. 08Nutriprem® 1
(Cow & Gate Ltd)
Liquid (sip feed)
per 100 mL335 kJ
( 80 kcal)2. 5 g
whey protein
and casein7. 6 g
(lactose 6. 3 g)4. 4 g 800 mg Contains soya, fish oil and egg
lipidLow birth-weight formula Nutriprem 1 liquid: 70 ml = Hospital
supply onlyNutriprem® 2
(Cow & Gate Ltd)
Liquid (sip feed)
per 100 mL310 kJ
( 75 kcal)2 g
whey protein
and casein7. 4 g
(lactose 5. 8 g)4 g 600 mg Contains soya, fish oil and egg
lipidCatch-up growth in pre-term infants
(less than 35 weeks at birth) and
small for gestational-age infants up to
6 months corrected age.Nutriprem 2 liquid: 200 ml = £ 1. 741018
Enteral feeds (non-disease speci
fi
c)BNFC
2018
– 2019
Borderline substances|Appendix 2A2